FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation
Cell Reports · 2024-08 · 43 (8) · 114609
DOI: 10.1016/j.celrep.2024.114609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-08. Verfasst von Jie Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: jiexu@med.umich…. Hauptthemen laut MEDLINE: Disulfiram, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Lipoylation. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: jiexu@med.umich.edu.
- Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Department of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: gabriel.nunez@umich.edu.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Xu, J., Pickard, J. M., & Núñez, G. (2024). FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation. Cell Reports, 43(8), 114609. https://doi.org/10.1016/j.celrep.2024.114609
Vancouver
Xu J, Pickard JM, Núñez G. FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation. Cell Reports. 2024;43(8):114609. doi:10.1016/j.celrep.2024.114609
BibTeX
@article{Xu2024,
author = {Xu, Jie and Pickard, Joseph M and Núñez, Gabriel},
title = {FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {8},
pages = {114609},
doi = {10.1016/j.celrep.2024.114609}
}
EUVIMED